Clinical trials: Postreperfusion Syndrome
Liver Transplantation, Postreperfusion Syndrome
Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation
The goal of this clinical trial is to test the efficacy of intravenous ascorbic acid in preventing the postreperfusion syndrome in liver transplantation.
- Conditions
- Liver Transplantation, Postreperfusion Syndrome, Ascorbic Acid
- Trial name
- VITACTOH (NCT05754242)
- Testing
- Ascorbic acid, 0.9% Saline solution
- Where
- Spain
- Volunteers
- 70 people
- Sponsor
- Hospital Universitario Ramon y Cajal
Liver Transplantation, Postreperfusion Syndrome
Comparison of PRS According to Inhalation Agent During LDLT
The investigators tried to evaluate the effect of desflurane on the incidence of postreperfusion syndrome during living donor liver transplantation surgery. The investigators used sevoflurane as a comparison.
- Trial name
- NCT01886664
- Testing
- sevoflurane, Desflurane
- Where
- South Korea
- Volunteers
- 70 people
- Sponsor
- Seoul National University Hospital
Liver Transplant Disorder
Effect of Mannitol on Postreperfusion Syndrome During Living Donor Liver Transplant
Postreperfusion syndrome during living liver transplants remains a serious concern for transplant anesthesiologists. This syndrome is responsible for decreases in systemic blood pressure, systemic vascular resistance, and cardiac…
- Trial name
- NCT05277623
- Testing
- Mannitol, 0.9% normal saline
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Ain Shams University
Postperfusion Syndrome
Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery
The incidence of postreperfusion syndrome (PRS) and vasoplegic syndrome (VS) is unknown, and occasionally can be confused since these syndromes share some hemodynamic characteristics.
- Trial name
- NCT05658120
- Testing
- noradrenaline/adrenaline
- Where
- Spain
- Volunteers
- 246 people
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
Liver Transplantation, Postreperfusion Syndrome
Effect of Nafamostat on Postreperfusion Syndrome (PRS)
This study intends to see the effect of nafamostat on the attenuation of postreperfusion syndrome (PRS) that frequently occurs during liver transplantation.
- Trial name
- NCT01001403
- Testing
- Nafamostat, Normal saline
- Where
- South Korea
- Volunteers
- 62 people
- Sponsor
- Seoul National University Hospital
Living Donor Liver Transplantation, Norepinephrine Bolus
Norepinephrine Boluses in Liver Transplantation
We study the efficacy of Norepinephrine boluses on prevention of postreperfusion syndrome during living donor liver transplantation.
- Conditions
- Living Donor Liver Transplantation, Norepinephrine Bolus, Postperfusion Syndrome
- Trial name
- NCT03773276
- Testing
- Norepinephrine boluses
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Mansoura University
Hypotension After Reperfusion in Liver Transplantation
Effect of Epinephrine/ Phenylephrine for Preventing the Postreperfusion Syndrome During Reperfusion in Liver Transplantation
Postreperfusion syndrome (PRS) is a relatively common phenomenon in patients undergoing liver transplantation which is characterized by an acute drop in blood pressure immediately after the prefusion is restored to the…
- Trial name
- NCT01080625
- Testing
- phenylephrine, epinephrine
- Where
- South Korea
- Volunteers
- 96 people
- Sponsor
- Seoul National University Hospital